Just weeks after its IPO, Cumberland Pharmaceuticals issued a release today declaring victory in its release of injectable ibuprofen drug Caldolor, on which heavily rested the case for the company's public stock offering.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment